{"doc_desc":{"title":"Impact of Combined Neoadjuvant Chemotherapy on the Complete Pathological Response Rate in Triple-Negative Breast Cancer","idno":"FReSH-83199-en","producers":[{"name":"Tohmas Martin","affiliation":""}]},"study_desc":{"title_statement":{"idno":"FReSH-83199-en","IDno":{"metadata_no":[{"agency":"","code":""}],"metadata_yes":[{"code":"FReSH","agency":"FReSH"}]},"title":"Impact of Combined Neoadjuvant Chemotherapy on the Complete Pathological Response Rate in Triple-Negative Breast Cancer","alternate_title":"ICNCP"},"study_authorization":{"agency":[{"name":"ANSM"},{"name":"CNIL"}]},"authoring_entity":[{"name":"Tohmas;Martin","firstname":"Tohmas","lastname":"Martin","type":"investigator","extlink":[{"title":"ORCID","uri":"","role":"pi id"},{"title":"IdRef","uri":"","role":"pi id"},{"title":"SIREN","uri":"602950206","role":"organisation id"},{"title":"ROR","uri":"https:\/\/ror.org\/05wz8pk64","role":"organisation id"},{"title":"RNSR","uri":"","role":"labo id"}],"email":"med8@impact-dev.tn","affiliationName":"ABBOTT FRANCE","PILabo":"","isContact":""}],"oth_id":[{"name":"Pharm ;10","firstname":"Pharm ","lastname":"10","type":"contributor","isContact":true,"extlink":[{"title":"ORCID","uri":"","role":"team member id"},{"title":"IdRef","uri":"","role":"team member id"}]},{"name":"ABBVIE","type":"affiliation","teamMemberLabo":"","extlink":[{"title":"SIREN","uri":"750775660","role":"organisation id"},{"title":"RNSR","uri":"","role":"labo id"}]},{"name":"","type":"collaboration"}],"production_statement":{"prod_place":"France Recherche en Sant\u00e9 Humaine (FReSH)","producers":[{"name":"AGENCE DE L ENVIRONNEMENT ET DE LA MAITRISE DE L ENERGIE (ADEME)","role":"sponsor","extlink":[{"title":"SIREN","uri":"385290309","role":"sponsor id"}]}],"funding_agencies":[{"name":"AEPEI (ASSOCIATION POUR L'ETUDE ET LA PREVENTION DES L'ENDOCARDITE INFECTIEUSE)","extlink":[{"title":"SIREN","uri":"428445696"}]}]},"distribution_statement":{"contact":[{"name":"Thomas;MARTIN","lastname":"MARTIN","firstname":"Thomas","type":"contact","email":"med8@impact-dev.tn","affiliationName":"ABBOTT FRANCE","contactPointLabo":"","extlink":[{"title":"SIREN","uri":"602950206","role":"organisation id"},{"title":"ROR","uri":"https:\/\/ror.org\/05wz8pk64","role":"organisation id"},{"title":"RNSR","uri":"","role":"labo id"}]},{"name":"Pharm ;10","lastname":"10","firstname":"Pharm ","type":"contact","email":"pharm10@impact-dev.tn","affiliationName":"ABBVIE","contactPointLabo":"","extlink":[{"title":"SIREN","uri":"750775660","role":"organisation id"},{"title":"RNSR","uri":"","role":"labo id"}]}]},"study_info":{"keywords":[{"keyword":"Free keywords"}],"topics":[{"topic":"Healthcare system determinants","vocab":"health determinant"},{"topic":"Healthcare system determinants: Access to care","vocab":"health determinant"},{"topic":"Healthcare system determinants: Quality of care","vocab":"health determinant"},{"topic":"Behavioral determinants","vocab":"health determinant"},{"topic":"Behavioral determinants: Eating habits","vocab":"health determinant"},{"topic":"Behavioral determinants: Hygiene","vocab":"health determinant"},{"topic":"Other","vocab":"health determinant"},{"topic":"Other factors, details","vocab":"other determinant"}],"purpose":"","abstract":"This study explores the efficacy of a neoadjuvant chemotherapy regimen in patients with locally advanced triple-negative breast cancer. The primary objective is to determine the rate of pathological complete response after treatment, as well as to evaluate tolerability and associated side effects. Patients are followed for a period of 24 months to also analyze recurrence-free survival and overall survival, with particular attention paid to biomarkers predictive of treatment response.","coll_dates":[{"start":"2026-09-08"}],"nation":[{"name":"France","abbreviation":"fr","extLink":{"vocab":"ISO","vocabURI":"fr"}}],"geog_coverage":"['Ile-de-France','Mayotte','Provence - Alpes - C\u00f4te d'Azur']","analysis_unit":"Individus","universe":"{\n    \"level_sex_clusion_I\": [\n        {\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"D005260\"\n            },\n            \"value\": \"Female\"\n        },\n        {\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"D008297\"\n            },\n            \"value\": \"Male\"\n        }\n    ],\n    \"level_age_clusion_I\": [\n        {\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"D055815\"\n            },\n            \"value\": \"Young Adult (19 to 24 years)\"\n        },\n        {\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"D000328\"\n            },\n            \"value\": \"Adult (25 to 44 years)\"\n        },\n        {\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"D008875\"\n            },\n            \"value\": \"Middle Aged (45 to 64 years)\"\n        },\n        {\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"D000368\"\n            },\n            \"value\": \"Aged (65 to 79 years)\"\n        }\n    ],\n    \"level_type_clusion_I\": \"General population\",\n    \"level_type_clusion_other\": \"\",\n    \"clusion_I\": \"\",\n    \"clusion_E\": \"\"\n}","data_kind":"['Clinical data','Paraclinical data (non-biological)','Paraclinical data (non-biological) : Anthropometry','Paraclinical data (non-biological) : Function testing','Other']","quality_statement":{"standards":[{"name":"","committee":"","governance":""}],"other_quality_statement":""}},"study_development":{"development_activity":[{"activity_type":"primary evaluation","activity_description":"Primary evaluation (assessment) criterion *\r\n"},{"activity_type":"secondary evaluation","activity_description":""}]},"method":{"data_collection":{"time_method":"","frequency":"Collection Frequency *\r\n","sampling_procedure":"['{\"concept\":{\"vocab\":\"CESSDA\",\"vocabURI\":\"Probability\"},\"value\":\"Probability\"}','{\"concept\":{\"vocab\":\"CESSDA\",\"vocabURI\":\"Nonprobability\"},\"value\":\"Non-probability\"}','{\"concept\":{\"vocab\":\"CESSDA\",\"vocabURI\":\"Other\"},\"value\":\"Other\"}']","sample_frame":{"frame_unit":{"unit_type":"['Administrative database (employees, pupils, students, etc.)','Disease and death registry','Other']"}},"coll_mode":["{\"concept\":{\"vocab\":\"CESSDA\",\"vocabURI\":\"Transcription\"},\"value\":\"Converting or copying information into a structured record\"}","{\"concept\":{\"vocab\":\"CESSDA\",\"vocabURI\":\"SelfAdministeredQuestionnaire\"},\"value\":\"Self-administered questionnaire\"}","{\"concept\":{\"vocab\":\"CESSDA\",\"vocabURI\":\"Other\"},\"value\":\"Other\"}"],"research_instrument":"","sources":[{"sourceCitation":{"titlStmt":{"titl":""},"holdings":"","notes":{"subject":"source purpose","value":""}},"srcOrig":[]}],"target_sample_size":"< 500 individuals","response_rate":""},"method_notes":"Observational Study","study_class":"Terminated study","notes":[{"subject":"research type","values":["Observational Study"]},{"subject":"observational study method","values":["Cohort study"]}]},"data_access":{"dataset_availability":{"access_place":"","complete":"","status":"{\"extLink\":{\"title\":\"COAR\",\"uri\":\"http:\/\/purl.org\/coar\/access_right\/c_abf2\"},\"value\":\"Open access\"}","notes":""},"dataset_use":{"restrictions":"","conditions":"","conf_dec":[{"txt":""}],"spec_perm":[{"txt":"","required":""}],"contact":[{"name":"Thomas;MARTIN","firstname":"Thomas","lastname":"MARTIN","email":"med8@impact-dev.tn"}],"deposit_req":"","cit_req":""}}},"additional":{"versionLang":"en","originLang":"en","lastUpdatedAuto":"08-09-2026","lastUpdatedManual":"08-09-2026","autoTranslation":true,"status":"Published","respValidation":"","isHealthTheme":false,"isContributorPI":true,"addTeamMember":true,"primaryInvestigator":{"isPIContact":"","piMail":"med8@impact-dev.tn","piAffiliation":{"piLabo":""}},"relatedDocument":[],"contactPointLabo":"","obtainedAuthorization":{"otherAuthorizingAgency":["",""]},"regulatoryRequirements":{"conformityDeclaration":""},"fundingAgent":{"fundingAgentType":["Private non-profit"],"otherFundingAgentType":[""]},"sponsor":{"sponsorType":["Public (France)"],"otherSponsorType":[""]},"governance":{"committee":false},"collaborations":{"networkConsortium":false},"theme":{"complementaryInformation":"","RareDiseases":false},"interventionalStudy":{"researchPurpose":[],"trialPhase":[],"interventionalStudyModel":"","isClinicalTrial":"","otherResearchPurpose":""},"isInclusionGroups":false,"allocation":{"allocationMode":"","allocationUnit":""},"masking":{"maskingType":"","blindedMaskingDetails":[]},"arms":[],"intervention":[{"name":"Name of the factor or exposure *\r\n"}],"cohortLongitudinal":{"recrutementTiming":[]},"otherResearchType":{"otherResearchTypeDetails":""},"inclusionGroups":[],"nrInclusionGroups":false,"collectionProcess":{"collectionModeDetails":"","collectionModeOther":"Alternative collection method: details\r\n"},"dataCollection":{"inclusionStrategy":[],"samplingModeOther":"Sampling Procedure Upon Inclusion *\r\n","recruitmentSourceOther":"Another source of recruitment: details\r\n","otherDocumentation":""},"activeFollowUp":{"isActiveFollowUp":false,"followUpModeOther":""},"dataCollectionIntegration":{"isDataIntegration":false},"geographicalCoverage":{"geoDetail":""},"dataTypes":{"clinicalDataDetails":"","biologicalDataDetails":"","biobankContent":[],"biobankContentOther":"","dataTypeOther":"Other types of data, details\r\n","paraclinicalDataOther":"","otherLiquidsDetails":""},"variableDictionnary":{"variableDictionnaryAvailable":false,"variableDictionnaryLink":""},"dataQuality":{"otherDocumentation":""},"mockSample":{"mockSampleLocation":""},"thirdPartySource":{"otherSourceType":[""]},"fileDscr":{"fileTxt":{"fileCitation":{"titlStmt":{"IDno":[]}}}},"creationDate":"08-09-2026","contributorName":"Tohmas Martin","contributorAffiliation":""},"schematype":"survey"}